Association of HLA-DR with susceptibility to and clinical expression of rheumatoid arthritis: Re-evaluation by means of genomic tissue typing

British Journal of Rheumatology

Volumn 37, Issue 4, 1998, Pages 411-416

  Van Jaarsveld, C H M ^a   Otten, H G ^a   Jacobs, J W G ^a   Kruize, A A ^a   Brus, H L M ^b   Bijlsma, J W J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Ziekenhuis Hilversum   (Netherlands)

Author keywords

Clinical expression; HLA DR; Immunogenetics; Rheumatoid arthritis

Indexed keywords

HLA DR ANTIGEN; HLA DR1 ANTIGEN; HLA DR2 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; HLA DR5 ANTIGEN; HLA DR6 ANTIGEN; RHEUMATOID FACTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; GENOME; HLA SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOGENETICS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS; TISSUE TYPING;

ADULT; AGE OF ONSET; AGED; ARTHRITIS, RHEUMATOID; FEMALE; GENOME, HUMAN; HISTOCOMPATIBILITY TESTING; HLA-DR ANTIGENS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RHEUMATOID FACTOR;

EID: 0031852218     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Winchester R. The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol 1994;56:389-466.
2. Paimela L, Leirisalo Repo M, Helve T, Koskimies S. The prognostic value of HLA DR4 and B27 antigens in early rheumatoid arthritis. Scand J Rheumatol 1993;22:220-4.
3. Wordsworth BP, Stedeford J, Rosenberg WM, Bell JI. Limited heterogeneity of the HLA class II contribution to susceptibility to rheumatoid arthritis is suggested by positive associations with HLA-DR4, DR1 and DRw10. Br J Rheumatol 1991;30:178-80.
4. Jeng-Hsien Y, Jong-Rern C, Wen-Juun T, Jih-Jin T, Hong-Wen L. HLA-DRB1 genotyping in patients with rheumatoid arthritis in Taiwan. J Rheumatol 1995;22:1450-4.
5. 1 epitope? Ann Rheum Dis 1991;50:295-7.
6. Stockman A, Emery P, Doyle T, Hopper J, Tait B, Muirden K. Relationship of progression of radiographic changes in hands and wrists, clinical features and HLA-DR antigens in rheumatoid arthritis. J Rheumatol 1991;18:1001-7.
7. Moreno I, Valenzuela A, Garcia A, Yelamos J, Sanchez B, Hernanz W. Association of the shared epitope with radiological severity of rheumatoid arthritis. J Rheumatol 1996;23:6-9.
8. van der Heide A, Remme CA, Hofman DM, Jacobs JWG, Bijlsma JWJ. Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis. Arthritis Rheum 1995;38:1466-74.
9. van der Heijde DM, van Riel PLCM, van Leeuwen MA, van 't Hof MA, van Rijswijk MH, van de Putte LBA. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients. Br J Rheumatol 1992;31:519-25.
10. Otten HG, Tilanus MGJ, Barnstijn M, van Heugten JG, Gast de GC. Serology versus PCR-SSP in typing for HLA-DR and HLA-DQ: a practical evaluation. Tissue Antigens 1995;45:36-40.
11. Bodmer JG, Marsh SGE, Albert ED et al. Nomenclature for factors of the HLA system, 1995. Vox Sang 1995;69:359-72.
12. van der Heide A, Jacobs JWG, Bijlsma JWJ et al. The effectiveness of early treatment with 'second-line' antirheumatic drugs. A randomized, controlled trial. Ann Intern Med 1996;124:699-707.
13. Arnett FC, Edworthy SM, Blog DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
14. van Riel PLCM. Disease assessment and outcome in rheumatoid arthritis. Rheumatol Eur 1994;23:128-9.
15. Sharp JT, Young DY, Bluhm GB et al. How many joints in the hands and wrists should be included in a score of radiologie abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 1985;28:1326-35.
16. Bijlsma JWJ, Oude Heuvel CHB, Zaalberg A. Development and validation of the Dutch questionnaire capacities of daily life (VDF) for patients with rheumatoid arthritis. J Rehabil Sci 1990;3:71-4.
17. Thompson PW, Silman AJ, Kirwan JR, Currey HLF. Articular indices for joint inflammation with rheumatoid arthritis. Correlation with the acute-phase response. Arthritis Rheum 1987;30:618-23.
18. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. Br Med J 1990;300:230-5.
19. Olerup O, Zetterquist H. HLA-DR 'low resolution' PCR-SSP typing - a correction and an update. Tissue Antigens 1993;41:55-6.
20. Nepom GT, Erlich H. MHC class-II molecules and autoimmunity. Annu Rev Immunol 1991;9:493-525.
21. Nepom GT, Byers P, Seyfried C et al. HLA genes associated with rheumatoid arthritis. Arthritis Rheum 1989;32:15-21.
22. Norusis MJ. SPSS/PC + ™ base manual. Chicago: SPSS, Inc., 1988.
23. Zeben van D, Hazes JM, Zwinderman AH et al. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a followup study. Arthritis Rheum 1991;34: 822-30.
24. Young A, Jaraquemada D, Awad J et al. Association of HLA-DR4/Dw4 and DR2/Dw2 with radiological changes in a prospective study of patients with rheumatoid arthritis. Arthritis Rheum 1984;27:20-5.
25. Eberhardt K, Grubb R, Johnson U, Petterson H. HLA-DR antigens, Gm allotypes and antiallotypes in early rheumatoid arthritis: their relation to disease progression. J Rheumatol 1993;20:1825-9.
26. Möttönen TT. Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Ann Rheum Dis 1988;47:648-53.
27. Gough A, Faint J, Salmon M et al. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum 1994;37:1166-70.